Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Ramsay Health Care ( (AU:RHC) ) has shared an announcement.
Ramsay Santé, a subsidiary of Ramsay Health Care, reported a 2.6% increase in revenue and a 6.5% rise in EBITDA for the quarter ending September 2025, despite challenges such as reduced public funding and cost inflation. The company’s strong performance, particularly in Sweden, was driven by activity growth, cost control measures, and strategic expansions, including new care models and facilities in France and Norway, which align with patient needs and enhance healthcare service quality.
The most recent analyst rating on (AU:RHC) stock is a Hold with a A$33.00 price target. To see the full list of analyst forecasts on Ramsay Health Care stock, see the AU:RHC Stock Forecast page.
More about Ramsay Health Care
Ramsay Health Care is a prominent player in the healthcare industry, primarily offering acute hospital services and healthcare facilities. The company operates in various regions, including Europe, with a significant focus on France and Sweden, providing quality care services in a competitive landscape.
Average Trading Volume: 701,379
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$7.08B
Find detailed analytics on RHC stock on TipRanks’ Stock Analysis page.